Breast Cancer
Showing NaN - NaN of 420
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Active, not recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +20 more
- Actigraph
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 4, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in Grand Rapids, New York, Houston (NGM438, Pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
-
Grand Rapids, Michigan
- +2 more
Jul 18, 2022
Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- AMXI-5001:Dose Escalation Phase I
- AMXI-5001:Dose Expansion Phase II
-
Phoenix, Arizona
- +7 more
Jul 18, 2022
Sentinel Lymph Node Biopsy, Breast Cancer, Melanoma Trial in Orange, Houston (pudexacianinium chloride)
Recruiting
- Sentinel Lymph Node Biopsy
- +2 more
- pudexacianinium chloride
-
Orange, California
- +1 more
Jul 11, 2022
Breast Cancer, HER2-positive Trial in Houston (Zanidatamab, Letrozole, Tamoxifen)
Recruiting
- Breast Cancer
- HER2-positive
- Zanidatamab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,
Recruiting
- Breast Cancer
- Solid Tumors
- PF-07220060 + PF-07104091 combination dose escalation
- +2 more
-
Grand Rapids, Michigan
- +1 more
Jun 28, 2022
Breast Cancer Trial in New York, Pittsburgh, Houston (Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions),
Recruiting
- Breast Cancer
- Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions)
- +2 more
-
New York, New York
- +4 more
Jun 29, 2022
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)
Not yet recruiting
- Tumors
- +4 more
- ZN-c3
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Jun 20, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Breast Cancer Trial in Houston (TAA-specific CTLs)
Active, not recruiting
- Breast Cancer
- TAA-specific CTLs
-
Houston, Texas
- +1 more
May 20, 2022
Breast Cancer Trial in Worldwide (Enzalutamide, exemestane, Placebo (for enzalutamide))
Breast Cancer, Gastrointestinal Cancer, Hematologic Cancer Trial in Houston (OPTIMISE)
Recruiting
- Breast Cancer
- +2 more
- OPTIMISE
-
Houston, TexasBaylor College of Medicine
May 16, 2022
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022